
Dr
Stephen
Angeloni
Dr
Stephen
Angeloni
Interim Director of LuminexPlore Lab
Luminex Corp.
Biography
I received my PhD in Biochemistry from Virginia Polytechnic Inst. and State University. I have been at Luminex for 14 years. Before joining Luminex I had over 30 years of research and industry experience with the development of a wide variety of biochemical, genetic, proteomic, immunology, microscopy, cellular, molecular biology assays and bioinformatic tools. These technologies were applied to studying genetic and environmental factors contributing to the susceptibility or resistance to a number of infectious and non-infectious diseases. This includes studies on disease mechanisms or treatments in the areas of endocrinology, cancer, obesity, diabetes and the development of DNA vaccines. These research efforts employed cellular, mouse and non-human primate model systems. This diversified experience has been applied to developing and supporting commercial applications for cellular genetic engineering, bioinformatic data analysis as well the development of genomic and proteomic assay platforms for research and diagnostics. This experience is now available for supporting the development of several applications on the Luminex xMAP platform. Research interests
Mainly development of multiplex assays for studying vaccine efficacy, pathogen titer detection, pathogen detection, and effectiveness of other therapeutics. Projects you're working on
Making different multiplex assays for pathogen detection and monitoring vaccine effectiveness in animals and humans. Discipline
Bioinformatics Cellular biology Challenge model development Commercialisation Deployment Epidemiology Immunology – innate Molecular biology Protein biology Virology Host species
Buffalo Camels Cats Cattle Dogs Horses Pigs Poultry Small ruminants Wildlife Pathogen
Viruses Stage of vaccine development
Antigen discovery and immunogen design Correlates of protection – immunomonitoring Deployment Field trials Pre-clinical trials